Announcements Trials
Browse Landscape

Phase

Phase 2 6

Status

Completed 3Recruiting 2Not yet recruiting 1

Sponsor Class

OTHER 6NETWORK 1INDUSTRY 1

Study Type

Interventional 6

Sponsor

Cancer Type

Gastrointestinal 6

Conditions

Colorectal Neoplasms 70Rectal Neoplasms 29Colonic Neoplasms 28Carcinoma, Hepatocellular 26Neoplasm Metastasis 15Stomach Neoplasms 12Pancreatic Neoplasms 7Cholangiocarcinoma 6Adenocarcinoma Of Esophagus 6Esophageal Neoplasms 5Recurrence 4Liver Neoplasms 4Biliary Tract Neoplasms 4Neoplasms 3Esophageal Squamous Cell Carcinoma 3Peritoneal Neoplasms 2Neoplastic Cells, Circulating 2Gastrointestinal Neoplasms 2Colorectal Cancer Metastatic 2Cirrhosis, Familial, with Pulmonary Hypertension 2Adenocarcinoma 2Postoperative Complications 1Peripheral Nervous System Diseases 1Pathologic Complete Response 1Pancreatic Adenocarcinoma 1Operable T2-3N+M0 Rectal Cancer (Stage III) 1Oligometastatic Gastric Adenocarcinoma 1Neurotoxicity Syndromes 1Neuropathy, Painful 1Neuralgia 1

Interventions

Fluorouracil 41Radiotherapy 38Cisplatin 35Oxaliplatin 32Leucovorin 24Paclitaxel 22Irinotecan 20Docetaxel 17Neoadjuvant Therapy 14Carboplatin 13Radiation 12Capecitabine 12Surgical Procedures, Operative 10Cetuximab 8Biopsy 8durvalumab 7Gefitinib 7Chemotherapy, Adjuvant 7tremelimumab 6pembrolizumab 6Nivolumab 6Magnetic Resonance Spectroscopy 6Folfox protocol 6Taxes 5Immunohistochemistry 5Endoscopy 5Gene Expression Profiling 4Epirubicin 4Drug Therapy 4dehydroftorafur 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
OTHER × Adenocarcinoma Of Esophagus × Folfox protocol × Clear all
NCT07603375 2026-05-29

TNT Esophagus

Duke University

Phase 2 Not yet recruiting
60 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Neoplasms

NCT06846346 2026-04-28

GRACIE

UNICANCER

Phase 2 Recruiting
88 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus, Adenocarcinoma, Neoplasm Metastasis, Neoplasms

NCT05476796 2024-10-24

LOGICAN

UNICANCER

Phase 2 Recruiting
118 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus, Adenocarcinoma, Neoplasm Metastasis, Recurrence

NCT00591123 2021-10-01

Study of Erlotinib and Chemotherapy for Unresectable or Metastatic Cancer of the Esophagus and Gastric Cardia

Translational Oncology Research International

Phase 2 Completed
38 enrolled 14 charts
Gastrointestinal

Adenocarcinoma Of Esophagus, Neoplasm Metastasis

NCT00381706 2021-09-29

Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer

Alliance for Clinical Trials in Oncology

Phase 2 Completed
245 enrolled 15 charts
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT00004127 2013-02-11

Oxaliplatin Combined With Fluorouracil and Leucovorin in Treating Patients With Recurrent or Metastatic Cancer of the Esophagus or Stomach

University of Chicago

Phase 2 Completed
35 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡